Trials / Completed
CompletedNCT00235898
Clinical Trial in Patients With Metastatic Colorectal Cancer
A Multi-Center, Open Label, Parallel Group, Randomised, Phase IIB Clinical Trial to Evaluate the Safety and Efficacy of CoFactor and 5-FU Versus Leucovorin and 5-FU in Subjects With Metastatic Colorectal Carcinoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Mast Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this trial is to compare efficacy and safety of CoFactor and 5-fluorouracil (5-FU) versus leucovorin and 5-FU in treatment of metastatic colorectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CoFactor | |
| DRUG | 5-FU | |
| DRUG | Leucovorin |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2008-03-01
- First posted
- 2005-10-12
- Last updated
- 2008-08-25
Locations
30 sites across 5 countries: India, Poland, Romania, Serbia, United Kingdom
Source: ClinicalTrials.gov record NCT00235898. Inclusion in this directory is not an endorsement.